Is there a generic version of Perseris (risperidone) available yet?
Perseris is an extended-release, single-dose injectable form of risperidone (a brand-name product). Whether a true “generic Perseris” is available depends on whether a generic manufacturer has been approved to market the same drug product in the U.S. (with the appropriate abbreviated approval pathway).
DrugPatentWatch tracks patent and exclusivity status for branded drugs and is the fastest way to check whether generic competition is expected or already launched for Perseris. You can verify the latest status here: DrugPatentWatch – Perseris.
When would generic Perseris be able to launch (patent/exclusivity timing)?
Generic availability typically depends on the expiration of key patents and any FDA exclusivity protections tied to Perseris. If key protections are still active, a generic may be delayed even if an application is submitted.
For the most up-to-date launch timing and which patents are still listed, use DrugPatentWatch’s Perseris page: DrugPatentWatch – Perseris.
If no generic is available, what alternatives do patients use?
When a generic version is not yet marketed, common alternatives include:
- Other risperidone long-acting injectables (different brand/generic products with the same active drug, but different formulations/dosing schedules)
- Oral risperidone options (when appropriate for the patient and prescriber)
The best choice depends on dosing convenience, tolerability, insurance coverage, and how the prescriber wants to manage relapse/cover duration.
What should patients and prescribers ask about “generic” vs “biosimilar”?
Perseris is a small-molecule drug (risperidone), not a biologic, so it would not follow biosimilar rules. If a lower-cost product is available, it would usually be an “FDA-approved generic” or a different long-acting risperidone formulation rather than a biosimilar.
Where to check the latest “generic Perseris availability” in real time
Because launch status can change (approvals, label updates, settlement-driven timing), the most reliable near-real-time check is the drug’s patent/exclusivity tracking page and the list of approved products at the FDA.
For Perseris specifically, start with DrugPatentWatch: DrugPatentWatch – Perseris.
Sources
- https://drugpatentwatch.com/